| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3cfba02fe25cf7ac80bc82819d81164 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate |
2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719845390a9a91797ae2effc85e6d1d7 |
| publicationDate |
2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013040153-A1 |
| titleOfInvention |
TREATMENT OF DISEASE OR DISORDERS CAUSED BY INDUCED NFkB TRANSCRIPTIONAL ACTIVITY |
| abstract |
The invention provides a method for treating a disease or disorder in a mammal which is caused by induced NFkB transcriptional activity in cells of the mammal, the method comprising administering to the mammal a compound that specifically inhibits one or more of CDK8 and CDK19. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019055977-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016348659-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017076968-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471446-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014071143-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019068613-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018139660-A1 |
| priorityDate |
2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |